FDA-Drug2026-07-01Class IIMISBRANDING
Major Pharmaceuticals Methylergonovine Maleate 0.2 mg tablets recalled for subpotency
What this means
MAJOR Pharmaceuticals is recalling Methylergonovine Maleate Tablets, USP, 0.2 mg due to subpotency — meaning the tablets contain less active ingredient than labeled. The affected lots were distributed nationwide. This is a prescription medication used to control bleeding after childbirth.
- If you have a prescription for this medication, contact your pharmacy or doctor immediately.
- Do not stop taking your medication without speaking to your doctor.
- Check the lot number on your bottle against the recall list: N02327 (expires 09/2026), N02740 (expires 12/2026), or N03069 (expires 08/2027).
The agency's original wording
Hazard
Subpotent Drug
Intended for
Adults
Illnesses reported
None reported
Sold states
U.S. Nationwide.
Affected count
790 Cartons.
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Products
Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0609-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.